Innoviva, Inc. (INVA) stock
INVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3039% below fair value
$18.40+0.10 (+0.55%)
Close on Nov 18, 2026Market cap $1.33BP/E 9.3Yield –
Innoviva profit margin
Profit margin (net margin) is net income as a percentage of revenue.
No profit margin figures for Innoviva
Innoviva has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?